Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Opdated results of the phase III keynote-048 study

by Harrington, Kevin J., Burtness, Barbara, Greil, Richard, Soulieres, Denis, Tahara, Makoto, de Castro Jr, Gilberto, Psyrri, Amanda, Brana, Irene, Baste, Neus, Neupane, Prakash, Bratland, Ase, Fuereder, Thorsten, Hughes, Brett G. M., Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Lin, Jianxin, Gumuscu, Burak, Swaby, Ramona F., Rischin, Danny
Published 2023

Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

by Keam, B., Machiels, J-P, Kim, H. R., Licitra, L., Golusinski, W., Gregoire, V, Lee, Y. G., Belka, C., Guo, Y., Rajappa, S. J., Tahara, M., Azrif, M., Ang, M. K., Yang, M-H, Wang, C-H, Ng, Q. S., Wan Ishak, Wan Zamaniah, Kiyota, N., Babu, S., Yang, K., Curigliano, G., Peters, S., Kim, T. W., Yoshino, T., Pentheroudakis, G.
Published 2021